222 related articles for article (PubMed ID: 22841132)
1. Penile Crohn's disease resolved by infliximab.
Lee Y; Lee YM; Kim MJ; Choe YH
J Crohns Colitis; 2013 May; 7(4):e146-9. PubMed ID: 22841132
[TBL] [Abstract][Full Text] [Related]
2. The effect of infliximab on extraintestinal manifestations of Crohn's disease.
Kaufman I; Caspi D; Yeshurun D; Dotan I; Yaron M; Elkayam O
Rheumatol Int; 2005 Aug; 25(6):406-10. PubMed ID: 15309501
[TBL] [Abstract][Full Text] [Related]
3. Metastatic crohn's disease--penile and scrotal involvement.
Martínez-Salamanca JI; Jara J; Miralles P; Berenguer J; Del Valle E; Hernández C
Scand J Urol Nephrol; 2004; 38(5):436-7. PubMed ID: 15764258
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
[TBL] [Abstract][Full Text] [Related]
5. Isolated penile lymphedema in an adolescent male: a case of metastatic Crohn's disease.
Sackett DD; Meshekow JS; Figueroa TE; Napoli JA
J Pediatr Urol; 2012 Oct; 8(5):e55-8. PubMed ID: 22507210
[TBL] [Abstract][Full Text] [Related]
6. Metastatic Crohn's disease: two cases of penile Crohn's and literature review.
Lane VA; Vajda P; King D; Stahlschmidt J; Sugarman I; Subramaniam R
J Pediatr Urol; 2010 Jun; 6(3):270-3. PubMed ID: 19800295
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Crohn's disease mimicking genital pyoderma gangrenosum in an HIV patient.
Avilés-Izquierdo JA; Suárez-Fernández R; Lázaro-Ochaita P; Longo-Imedio I
Acta Derm Venereol; 2005; 85(1):60-2. PubMed ID: 15848994
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease and hidradenitis suppurativa. An uncommon association that responds to infliximab.
Blazquez I; Gonzalez-Lama Y; Roustan G
J Crohns Colitis; 2013 Dec; 7(12):e717-8. PubMed ID: 24080248
[No Abstract] [Full Text] [Related]
9. Metastatic Crohn's disease in a boy presenting with genital swelling.
Mazzoni D; Bodapati S; Mortimore R; Davies J; Wheller L
Pediatr Dermatol; 2020 Nov; 37(6):1165-1166. PubMed ID: 32965062
[TBL] [Abstract][Full Text] [Related]
10. Penile and scrotal lymphedema as an unusual presentation of Crohn's disease: case report and review of the literature.
Reitsma W; Wiegman MJ; Damstra RJ
Lymphology; 2012 Mar; 45(1):37-41. PubMed ID: 22768472
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
[TBL] [Abstract][Full Text] [Related]
13. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
[TBL] [Abstract][Full Text] [Related]
14. A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.
Lim CS; Moon W; Park SJ; Park MI; Kim HH; Kim JB; Choi JM; Chang HK; Lee SH
Korean J Gastroenterol; 2013 Sep; 62(3):169-73. PubMed ID: 24077628
[TBL] [Abstract][Full Text] [Related]
15. Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.
Szabó D; Kökönyei G; Arató A; Dezsőfi A; Molnár K; Müller KE; Lakatos PL; Papp M; Lovász BD; Golovics PA; Cseh A; Veres G
J Crohns Colitis; 2014 Aug; 8(8):747-55. PubMed ID: 24434181
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
17. Is really megacolon a contraindication to infliximab in Crohn's disease?
Sinagra E; Orlando A; Renna S; Criscuoli V; La Seta F; Olivo M; Ciofalo M; Cottone M
Acta Gastroenterol Belg; 2013 Dec; 76(4):442-4. PubMed ID: 24592552
[TBL] [Abstract][Full Text] [Related]
18. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
Sisman G; Erzin Y; Bal K
J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
[No Abstract] [Full Text] [Related]
19. FOXP3+ regulatory T-cell counts correlate with histological response in Crohn's colitis treated with infliximab.
Sloan S; Maxwell P; Salto-Tellez M; Loughrey MB
Pathol Int; 2014 Dec; 64(12):624-7. PubMed ID: 25354875
[TBL] [Abstract][Full Text] [Related]
20. Development of diffuse alopecia with psoriasis-like eruptions during administration of infliximab for Crohn's disease.
Kawashima K; Ishihara S; Yamamoto A; Ohno Y; Fukuda K; Onishi K; Kinoshita Y
Inflamm Bowel Dis; 2013 Mar; 19(3):E33-4. PubMed ID: 22508420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
